Catalan Life Sciences Database

TAIPEI, Taiwan and TOKYO, March 5, 2019 /PRNewswire/ -- Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and facilitate communication between diabetics and healthcare providers. Last December, the two companies agreed to support the localization... Read more ››

By: PR Newswire Association LLC. - 05 Mar 2019

Growing Adoption of AlgaPrime(TM) DHA is Improving Omega-3 Content of Farmed Fish and Accelerating Sustainable Aquaculture

BERGEN, Norway, March 5, 2019 /PRNewswire/ -- Corbion, the global market leader in algae-based food ingredients and BioMar, the leading innovator... Read more ››

By: PR Newswire Association LLC. - 05 Mar 2019

Novo Nordisk A/S - Share repurchase programme

By: Nasdaq / GlobenewsWire - 04 Mar 2019

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

By: Nasdaq / GlobenewsWire - 04 Mar 2019

Sanofi : CHMP recommends ZynquistaTM (sotagliflozin) for the treatment of adults with type 1 diabetes

By: Nasdaq / GlobenewsWire - 01 Mar 2019

Sanofi: CHMP recommends approval of Dupixent® (dupilumab) for asthma indication

By: Nasdaq / GlobenewsWire - 01 Mar 2019

« 1 2 3 4 5 6 7 »

Looking for companies outside of Catalonia?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

April 2019
- London: BioTrinity 2019
May 2019
- Basel: Swiss Biotech Day
- Shanghai: Pharma - Biotech Product and Company Valuation Workshop

See Events »

Add an Event »

Latest company news

Cariprazine Shows Better Cognitive Improving Features and Uniquely Favorable Weight Gain Effect Compared to Other Antipsychotics
16 Apr 2019 (PR Newswire Association LLC.)

Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer
16 Apr 2019 (PR Newswire Association LLC.)

Tessa Therapeutics Announces Collaboration with MSD Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer
16 Apr 2019 (PR Newswire Association LLC.)

News in the Life Sciences Industry

Looking for companies outside of Catalonia?

Partners

Upcoming Life Sciences Events

Latest company news